Liraglutide (as Victoza) and semaglutide (as Ozempic) are both approved diabetes medications
They reported that LGMSCs and their derived Exos decrease inflammatory cells infiltration to salivary glands and reserve their secretory function in non-obese diabetic (NOD) mice, raise regulatory T cells proliferation and inhibit T helper-cell 17 differentiation in NOD mice and SS patients invitro with increase Tcell secretions of IL-10 and transforming growth factor beta(TGF-) and decreased cytokine levels(IL-6, IL-17, Interferon-gamma) (85)
Frederiksen Y, Farver-Vestergaard I, Skovgrd NG, Ingerslev HJ, Zachariae R
Sanofi developed Toujeo as the next generation of their insulin glargine line
Patients initiating GLP-1 therapy for diabetes or weight management who also experience joint pain should maintain a comprehensive approach to musculoskeletal health
Add Phormula-1 Clear protein to your GLP-1 diet to help get that extra protein in every day